Storia della carriera di Scott Carmer
Precedenti posizioni note di Scott Carmer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NEXIMMUNE, INC. | Direttore/Membro del Consiglio | 01/01/2017 | 12/02/2022 |
| Amministratore Delegato | 01/03/2018 | 12/02/2022 | |
| Direttore operativo | 01/07/2015 | 01/03/2018 | |
| Corporate Officer/Principal | 01/02/2014 | 01/07/2015 | |
| Presidente | 01/03/2018 | 12/02/2022 | |
Orgenesis Maryland, Inc.
 Orgenesis Maryland, Inc. Pharmaceuticals: MajorHealth Technology Part of Orgenesis, Inc., Orgenesis Maryland, Inc. develops a novel therapeutic for the treatment of diabetes. The company is based in Germantown, MD. | Amministratore Delegato | 04/08/2014 | 18/11/2016 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - | - |
| AMGEN INC. | Corporate Officer/Principal | - | - |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 11/04/2011 | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Vendite & Marketing | - | - |
Formazione di Scott Carmer
| University of Kentucky | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Canada | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 2 |
| Sales & Marketing | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| NEXIMMUNE, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Orgenesis Maryland, Inc.
Orgenesis Maryland, Inc. Pharmaceuticals: MajorHealth Technology Part of Orgenesis, Inc., Orgenesis Maryland, Inc. develops a novel therapeutic for the treatment of diabetes. The company is based in Germantown, MD. | Health Technology |
- Borsa valori
- Insiders
- Scott Carmer
- Esperienza
